1. Drug Repurposing: Promises of Edaravone Target Drug in Traumatic Brain Injury
   Zaynab Shakkour et al, 2021, Current Medicinal Chemistry CrossRef
2. Ferroptosis regulation through Nrf2 and implications for neurodegenerative diseases
   Yao Xiang et al, 2024, Archives of Toxicology CrossRef
3. Oxidative Stress in Amyotrophic Lateral Sclerosis: Pathophysiology and Opportunities for Pharmacological Intervention
   Teresa Cunha-Oliveira et al, 2020, Oxidative Medicine and Cellular Longevity CrossRef
4. Edaravone Plays Protective Effects on LPS-Induced Microglia by Switching M1/M2 Phenotypes and Regulating NLRP3 Inflammasome Activation
   Jiping Li et al, 2021, Frontiers in Pharmacology CrossRef
5. Sorafenib and edaravone protect against renal fibrosis induced by unilateral ureteral obstruction via inhibition of oxidative stress, inflammation, and RIPK-3/MLKL pathway
   Mohamed A. Abou Taha et al, 2024, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
6. A Perspective on Nrf2 Signaling Pathway for Neuroinflammation: A Potential Therapeutic Target in Alzheimer's and Parkinson's Diseases
   Sarmistha Saha et al, 2022, Frontiers in Cellular Neuroscience CrossRef
7. Edaravone Alleviates Traumatic Brain Injury by Inhibition of Ferroptosis via FSP1 Pathway
   Haoyu Shi et al, 2024, Molecular Neurobiology CrossRef
8. Repurposing of Various Current Medicines as Radioprotective Agents
   Rajwinder Kaur et al, 2023, Anti-Cancer Agents in Medicinal Chemistry CrossRef
9. Enhancing the Neuroprotection Potential of Edaravone in Transient Global Ischemia Treatment with Glutathione- (GSH-) Conjugated Poly(methacrylic acid) Nanogel as a Promising Carrier for Targeted Brain Drug Delivery
   Faezeh Mozafari et al, 2023, Oxidative Medicine and Cellular Longevity CrossRef
10. Edaravone in the treatment of concussion and post-concussion syndrome
    O.A. Halushko, 2023, Infusion & Chemotherapy CrossRef
11. An Exploratory Trial of EPI-589 in Amyotrophic Lateral Sclerosis (EPIC-ALS): Protocol for a Multicenter, Open-Labeled, 24-Week, Single-Group Study
    Shotaro Haji et al, 2023, JMIR Research Protocols CrossRef
12. Edaravone Attenuates Disease Severity of Experimental Auto-Immune Encephalomyelitis and Increases Gene Expression of Nrf2 and HO-1
    D MICHALIČKOVÁ et al, 2022, Physiological Research CrossRef
13. Edaravone mitigates hemorrhagic cystitis by modulating Nrf2, TLR‐4/NF‐κB, and JAK1/STAT3 signaling in cyclophosphamide‐intoxicated rats
    Emad H. M. Hassanein et al, 2021, Journal of Biochemical and Molecular Toxicology CrossRef
14. Nrf2 Ablation Promotes Alzheimer’s Disease-Like Pathology in APP/PS1 Transgenic Mice: The Role of Neuroinflammation and Oxidative Stress
    Peng Ren et al, 2020, Oxidative Medicine and Cellular Longevity CrossRef
15. NIR-II Dyad-Doped Ratiometric Nanosensor with Enhanced Spectral Fidelity in Biological Media for In Vivo Biosensing
    Peng Yu et al, 2022, Nano Letters CrossRef
16. Drug Repurposing in Neurological Disorders: Implications for Neurotherapy in Traumatic Brain Injury
    Zaynab Shakkour et al, 2021, The Neuroscientist CrossRef
17. Auricular Electroacupuncture for Late Posttraumatic Epilepsy after Severe Brain Injury: A Retrospective Study
    Cui-Cui Shen et al, 2019, Evidence-Based Complementary and Alternative Medicine CrossRef
18. Edaravone Dexborneol Alleviates Cerebral Ischemic Injury via MKP-1-Mediated Inhibition of MAPKs and Activation of Nrf2
    Wen Zhang et al, 2022, BioMed Research International CrossRef
19. Docetaxel-induced cognitive impairment in rats can be ameliorated by edaravone dexborneol: Evidence from the indicators of biological behavior and anisotropic fraction
    Ping Liu et al, 2023, Frontiers in Neuroscience CrossRef